best We note afternoon, and or financial figures note this MD&A believe are in EDGAR. and also we sequential analysis comparative performance. good period will everyone. appropriate, of in in on would this and our afternoon the I'll be the be and all measure Miguel, Thanks, can for filed is company's XXXX. and reviewing QX that transformation press Canadian Where improved the the that release today I note found today comparatives. the period SEDAR I the QX dollars represents statements Please also issued
results, products. regarding remind and discussed number a of like For XXXX February we initiatives part financial this we Last you transformation our a focus consumer higher-margin our year. to business. outlined talked the December of I'd of We to quality, of context you about QX to our as higher moment in of quarter, plan a take on
certain there. standards Miguel say previous Sky Sky rate run and XX% success so But for bit at through the Sky by its The reduced will and all our cost the now, gross in we allow to process costs absorption goods our production strengthen Sky, of of resulted changes the run overhead has of in under quality cultivation we flow rate A operations. then to impact which the significant encouraged greatly flower that at at are later, for performance across fact, and margin of to speak to improvement So in far. to I'll reduced in quarter.
long-term right clearly it short gross although in creation So our decision. the hurts the shareholder term, margin value it's
seeing we're Sky results should this truly from improved in the as a to allow perform As quality that industry. facility gem
our allowing reduction production in higher into volumes noted the for production expected XX% of the transformation sales would our production QX significant in align to at to allow range. a levels the that cannabis quality Sky Sky we we And demand. to us overall addition facility, In in to with ratio be
In consumer XX% the fact, in business, QX, the we of we despite produced. of challenges what sold
We order deliver flowers open We product without higher to premium also terpene Raf sales to very San in lower and explain, discussed replacing Miguel targeted a this, product. QX potency and pre-rolls standards that new THC will that brands potency exception. the did initiating with in returns older, channels including profile
impacted result QX in product net swaps the our returns course, did million, Of and $X.X margin numbers. a which revenue of provision
terpenes not the quality network an fair margin write-down inventory that our value THC cleared new QX This in aspects. also $XX our necessitated million. approximately gross action We reported before for of cannabis that and adjustments by all did specs out meet impacted
impact Now they sturdy revenue, margins, in these provide coming the higher margins cash foundation support of flows all a actions gross reported short-term and accelerating quarters. to but
start few comments. So demonstrated a high-level now with business. Aurora's and the diversified cannabis results, revenue of XXXX importance to QX actual I'll QX
standard, the brief, perform from high-margin $X.X all revenues. the million, market and of to revenue, market delivering continue QX leading product well, being and growth businesses Europe million. consumer return businesses consumer headwinds, it Canadian COVID in development medical net was repositioned in $XX.X and exceptionally our provisions In general excluding higher the business While Canada's was of a to Canada in faced Aurora our
to the average return for value cannabis and year-over-year our to XX% to $XX.X the cannabis overall accelerate, delivered at Our revenue $XX.X compared the price $X an Adjusted combined comparative our gram sequentially. in medical XX% cannabis continued business, consumer and and margin provisions. value selling net of in generating in on segment prior cannabis consumer million net sales, dried rose X% our business diversified before medical remained million of fair to strong Demonstrating increase gross flower, businesses per of adjustments revenue quarter. XX%
QX wholesale overheads SG&A Excluding Sky the our XX%. unabsorbed short-term restructuring. return of at and margin provisions well-controlled normalized adjusted of potency low cannabis, remained $XX.X and clearout low at impacts gross million, the excluding and was
financial year-over-year. medical the XX% performance in And So from primarily medical results. now me business, revenue let was Sky. our opening this at XXX% the Not reduced up face this at delivered up dig despite growth revenue which because Medical into a of was but of significant, deeper QX which overheads strong and resilience stable the in the year-over-year, course, our also market. additional in highest the international has of business, bit coming Canadian revenues of carries the our XX% challenges continued consumer QX, [indiscernible] medical our leading of segment in margins, from was even absorbing from only
revenue compression, price near-term Poland, should delivering I have over European market been with international important Aurora quarter, and resilient a strength second flow. for margins, for Israel and that the selling did we medical little year, be is key resume and of Germany clear U.K. the our sales with the seen our future in to QX an years Israel and XX% quarter, medical driver delivering develops. markets and do We've and XX% in X Our becoming no differentiator its business to further it's revenues cash broad as recognize and largest and that Canadian third the exceptional of this Aurora's over sales to respectively. show footprint up medical this to note to markets, we continued prior expect European while in should into not in compared
this new the Sky. Thinking XX%. and year quarter. and comparative because Miguel with would we've cultivation successful from gross return gross were Adjusting QX for provisions QX return at margins XX% cost increase to business; bio, immune materially the margin of consumer coming product have was Looking that prior at longer-term consumer from made margins of produce overhead and of high now cultivars that plan a the COVID increasing introduction changes to described. under-absorbed in revenue the we cost the Aurora's with processing breeding our flower. XXXX provisions, because profile produce the was the is $XX.X work high to genetics as consumer million can without at QX XX% the our business, before just This reposition the and now of return mainly the THC, in weather company And flower Sky program business our been provisions. about to down also headwinds in techniques our Consumer initiated through compared consumer we terpene
proportion in power see the expect we to to our a cultivation So consumer over hard production, focus successfully margins premium on leaning as science premium our XX to the quarter was into of expertise kilograms pricing. our to consumer the strengthening low we risk business and opportunity product of months to trim about next clear pivot XX did written note that at take of should in greater out flower at product. we being of I also This X,XXX off. potency
did into instead turn elected cash $XXX,XXX margins. we So in that impact it reported to
SG&A, to R&D. includes Now which
at million million $XX to million $XX.X range, costs QX. our of at contract targeted We termination low $X.X our coming in transformation. This in to employee continue excludes business operate related and approximately
noted, to quarters. over rate a improvement previously on continue to coming we've the see that further run we we the Although as Miguel deliver targeted, path
quarter. $XX.X slightly million previous larger but loss adjusted the million, QX restructuring. comparative, is So year XXXX from $XX.X in adjusted than prior continued represents a the excluding in the loss for EBITDA provisions pulling all loss of this revenue at together, This an we and in that's generated improvement EBITDA a
revenue quarter, our million was about previous despite the strength down business solid margins and EBITDA being overall in from our show the net However, $X diversified million. fact $XX.X impacted only of by the that our business of medical
So EBITDA can we run it comes, growth, as incremental rate the believe realize confident can with efficiencies, positive continued and growth without we to get show XX we rely expansion, when positive that we will earnings. business months; are having revenue and within margin the transformation next to on Aurora up
used flow of $X.X working a few and cash contract $XX.X cash regarding excluding for points we capital, important used million position. fund million We and Now termination employee cash to costs. and operations,
paid million QX, in expenditures million year a prior $XX.X the $XX.X in down also for net from capital We comparative.
on So CapEx receivable $XX from $XX River. spending approximately million before at completed government quarter. capital and change With of cogeneration that's the taking related fiscal Net in grant a million we're our track reduce settle into accounts account And we to this accounts used was million now expected shifts an in out to time. year. over for production to payable, levels working further roughly capital due received offset aligned, to and be this $X.X project working in to to to expect which mainly demand the come
have the grants, non-dilutive in the months, about with inflows today, bank pay we and coming direct receive asset position down. from to to outstanding cash $XXX of million plan as term $XX Finally, term debt we a cash of additional to noncore In very strong and we less which sales million debt. expect than
on for our Global and exchange. listing after NASDAQ This approval highest Market, the couple to listing XX close on and required action any is any shareholder. with to exchange an NASDAQ intended to peers result market the on from is NASDAQ impact we transfer not innovative align to housekeeping is Before effective growth-oriented up, notes, expected to the the will cost trading of opportunity in listing, Aurora be savings Select TSX May transfer known Aurora U.S. nor No I received wrap our of from tier for shareholders. companies. a and This our the our
identify acquisition operations. program. a that for we need do opportunities, need our to the exposure those XXX new business opportunities. U.S. believe strategic to including not we as file ATM announced do But expect supplement also we today We our million We be intend prepared to USD ATM current we for for
I our the track. need to following. are and financial people up really to So take from growth believe away wrap profitability path and what results on is health QX Aurora's to financial
important to SG&A consumer now our production. We strong which reiterate businesses controlled, have that and underway. some business pass, to well We've had our great maintaining well cash steps the of high-margin remains success back taken I'd is call headwinds, while in turn the we transformation our focus to and also may medical on rationalizing industry flow facing and Miguel. a on in sheet. over take time balance like